Skip to main content

Prostate Cancer

Prostate cancer is a type of cancer that occurs in the prostate gland in men. The prostate is a walnut-shaped small gland and part of the reproductive system in males that makes seminal fluid. It nourishes and sends sperm.


Prostate cancer is a common form of cancer. The growth of prostate cells can be slow and restricted to your prostate gland. In that case, it may not lead to serious damage, or even you do not need treatment. Early detection of prostate cancer can make treatment successful.


What are the symptoms of prostate cancer?


Prostate cancer may not lead to any signs or symptoms in its early stages. In advanced stages, it can show signs and symptoms, such as.

    ● Feel difficulty while urinating.

    ● Having blood in the urine.

    ● Having blood in the semen.

    ● Pain in bone.

    ● Loss of appetite

    ● Weight loss

    ● Painful ejaculation.

    ● Lower back, hips, or upper thigh pain.

    ● Feel dull pain in the pelvic zone.

What are the causes of prostate cancer?


The cause of prostate cancer is unclear. Doctors say that it happens when the cells of the prostate start changes in their DNA. A cell's DNA contains instructions that inform the cells what to do. The changes instruct the cells to grow and divide more quickly than normal cells do. The abnormal cell continues to exist when other cells die. The accumulation of abnormal cells forms a tumor that can grow to attack nearby tissue. Over time, some abnormal cells may separate and "spread to other areas of the body.



Some risk factors may increase the risk of prostate cancer, including:

    ● Old age

    ● Family history

    ● Race

    ● Overweight/obesity

Treatment


Early detection can save lives. It can help to prevent the spread to other parts of the body, such as lymph nodes or bones. If a person is detected early, there is a good chance of survival. Treatment also depends on the stage of cancer, age, health, and risk category.


Prostate cancer happens when the cells in the prostate gland (found only in males which resides 
between the penis and bladder) start to grow out of control. While this cancer is quite common, 
doctors have prescribed Zytiga 250mg tablet as one of the medications.  
Zytiga 250mg tablets is an anti-cancer medication, which works by stopping the growth of 
cancer cells in the body. It is often used with other medications as well. It is usually taken on an empty stomach. However, this medicine is not that much affordable. 


 

Comments

Post a Comment

Popular posts from this blog

Why are children more susceptible to lung cancer?

Lung cancer is an unfortunate reality that has been on the rise among all populations regardless of age. Still, in recent years, the data has revealed a startling trend that children are more susceptible to the disease than ever before. While there is still a lot of disagreement as to why this is, it is important to recognize that children are especially vulnerable, and, as a result, specific measures must be taken to protect them from developing such an illness. To better understand the issue, this paper will explore the causes of why children are more prone to lung cancer, the symptoms, and the current preventive measures to protect them from this deadly illness. The reason behind the increase in childhood lung cancer The primary cause of the increase in childhood lung cancer cases has been linked to environmental factors and lifestyle choices. Studies show that exposure to chemicals and other pollutants, secondhand smoke, and other toxic substances can contribute to the development ...
Post a Comment
Read more

Role of Alectinib

Alectinib is a novel FDA-approved, targeted therapy used to treat ALK(anaplastic lymphoma kinase)-positive advanced non-small-cell lung cancer (NSCLC). NSCLC is the most common type of lung cancer and is the leading cause of cancer-related deaths worldwide. ALK-positive NSCLC is a rare and aggressive form of lung cancer caused by a genetic abnormality in the ALK gene. Alectinib works by specifically targeting the cancer cells with the abnormal ALK gene, potentially providing a more personalized approach to treating NSCLC. Dosage of alectinib administration Alectinib is administered as a once-daily 150mg dose either orally or intravenously. It is combined with other drugs such as chemotherapy, immunotherapy, and other targeted therapies following the progression or recurrence of the disease. Alectinib has displayed superior efficacy in comparison to other existing ALK inhibitors such as crizotinib, with higher response and progression-free survival rates. Side effects due to alectinib A...
Post a Comment
Read more